Message from the President
Dear ISPD Friends and Colleagues,
It is hard to believe that 2021 is coming to a close. It has been an extraordinary year and an extremely busy one both for ISPD and for me personally. I hope that like me, you are now very much looking forward to some relaxation around the holidays!
I just finished moderating a session of the ISPD Virtual Education Series (VES), which thanks to our Education Fund with Corporate Council support, we are able to offer free to all. November’s topic was "Genetic work-up of increased nuchal translucency." This was our fifth ISPD webinar offered this year, and it was well attended with a lot of questions. We hope you are enjoying the VES sessions; there is one more to come this year on agenesis of the corpus callosum. I want to thank all our speakers for volunteering their time and expertise to be a part of these. They really have been excellent, and all the recordings are available on the ISPD website.
ISPD has also been very active this year with global outreach. Again with Education Fund support, and with Global Education and Outreach Chair Rossa Chiu leading the charge, ISPD is working with organizations and societies in China, Singapore, Taiwan, and Peru to deliver courses and webinars. I spoke at the one in Taiwan last weekend and it was great to have live discussion with colleagues from many miles away. Time differences can be challenging, but we seem to be managing. The combination of a recorded talk and live Q&A seems to work well. The Board of Directors believes this type of educational outreach is key to ISPD furthering it's mission of advancing the science and practice of genetics and fetal care worldwide to promote the health of children, their mothers, and their families. If you have any ideas of societies who may like to partner with us on an outreach course, please get in contact so we can explore new avenues.
We are working very hard on the 26th International Conference on Prenatal Diagnosis and Therapy, for which we will be offering both in-person and remote attendance options to participants and speakers. This will be the first “hybrid” conference ISPD has conducted, and we hope it will allow participants who might not otherwise be able to attend the opportunity to hear about the latest in prenatal diagnosis and therapy. The call for abstracts was just been released, so please do consider submitting an abstract for an oral presentation or a poster. The deadline is 17 January 2022. While we believe the remote participation option is important especially this year, we do hope that a good portion of our community will be able to attend in person on 19-23 June 2022 in Montréal, which is truly a fabulous city. If you like Formula 1 racing, the Montréal Grand Prix will take place on 19 June 2022, the Sunday before our meeting begins. We will hold a small offsite Fetal Therapy hands-on workshop that day, the conference Monday-Wednesday, 20-22 June 2022, and finish up with post-conference courses on Thursday, 23 June 2022. The conference will feature some really exciting debates and plenary sessions, so you will not want to miss it.
Finally, I want to urge you to consider nominating a colleague or yourself to serve on the ISPD Board of Directors or as a SIG Co-Chair. Nominations are open through Wednesday, 1 December 2021. If you’re interested in helping ISPD continue to grow, please consider putting your name forward.
Lyn Chitty, PhD, MRCOG